Skip to content
healthcare.dev

dasatinib

NDC 70710-1743, dasatinib, tablet, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1743
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218719
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1743 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DASATINIB70 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
70710-1743-67071017430660 TABLET in 1 BOTTLE (70710-1743-6)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/11703145-29ea-480a-9810-bc70663b783f

Use it

Look up 70710-1743 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1743 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1743. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.